Effects of the Once-Weekly DPP4 Inhibitor Omarigliptin on Glycemic Control in Patients with Type 2 Diabetes Mellitus on Maintenance Hemodialysis: A 24-Week Open-Label, Multicenter Randomized Controlled Study

INTRODUCTION: Dipeptidyl peptidase 4 (DPP4) inhibitors are widely used in patients with type 2 diabetes mellitus (T2DM) on maintenance hemodialysis (HD), but the efficacy of the once-weekly DPP4 inhibitor omarigliptin is not known. METHODS: This prospective, randomized, open-label, parallel-group, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshizawa, Yuta, Hosojima, Michihiro, Kabasawa, Hideyuki, Tanabe, Naohito, Ugamura, Daisuke, Koda, Yutaka, Shimada, Hisaki, Takasawa, Tetsuya, Ito, Takahito, Kitamura, Tadahiro, Kobayashi, Masaki, Suzuki, Yoshiki, Narita, Ichiei, Saito, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947073/
https://www.ncbi.nlm.nih.gov/pubmed/33474645
http://dx.doi.org/10.1007/s13300-020-00991-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947073/
https://www.ncbi.nlm.nih.gov/pubmed/33474645
http://dx.doi.org/10.1007/s13300-020-00991-y

Ejemplares similares